› Forums › Cutaneous Melanoma Community › Late (>1yr) cutaneous adverse events to PD-1 Keytruda
- This topic has 6 replies, 5 voices, and was last updated 7 years, 6 months ago by
Casitas1.
- Post
- Replies
-
-
- November 8, 2017 at 2:50 am
After three Keytruda treatments I had a severe rash on legs and arms which was cleared up with prednisone. About six weeks later vitiligo started on legs and arms also. Treatment was stopped and the last three scans have been stable. I had nivo/Yervoy previously and had two reactions. I respond well to immunotherapy but it "overstimulates" my immune system. It seems the vitiligo issue is a good sign that the Keytruda continues to work – let's hope. Hope your rash clears up and can continue with treatment,
-
- November 8, 2017 at 3:39 am
I have also read (and I believe bubbles has some solid data on her blog) about rashes and vitiligo being positively prognostic for responding to immunotherapy. I recently completed only my second dose of Keytruda and had a brief rash the first time (which might have been due to the additional treatment with PV-10), and no skin symptoms the second time around (about 7 days ago now). I have had some flu like symptoms and fatigue (both fairly mild) which resolved within days of the treatment, but again I am new to the treatment. So, are you experiencing this after one year of treatment or one year after finishing treatment?
-
- November 8, 2017 at 2:44 pm
We have learned that late response….esp "late" side effects are actually fairly common with immunotherapy.
Here is a post and report from experts in 2015 (check out the top section of points with an asterisk):
Celeste
-
- November 9, 2017 at 5:41 am
I have been NED 16 months and off treatment (Keytruda) for one year now. about a month ago i had joint pain increase and Pancreatitis flare up. Those i had during treatment. a wierd rash as well was new groin area and under left arm. Maybe my immune system is permanantly rigged this way? Not complaining though.
Best, Paul
-
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.